B cell CLL (>95% of cases) is characterised by clonal expansion and accumulation of immature CD5+/CD19+ B cells in the bone marrow and lymph nodes, where oncogenesis is believed to be driven by microenvironment signals, and in the peripheral blood [96]. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.